Influence of magnesium ion on the binding of p53 DNA-binding domain to DNA-response elements

Journal of Biochemistry

Volumn 146, Issue 1, 2009, Pages 77-85

  Xue, Yonglai ^a   Wang, Shuai ^a   Feng, Xizeng ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

Affinity; Association constant; Conformational change; DNA binding activity; Fluorescence; Protein DNA interaction

Indexed keywords

MAGNESIUM ION; PROTEIN P53; TRYPTOPHAN; ZINC ION;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CANCER INHIBITION; CIRCULAR DICHROISM; CONCENTRATION (PARAMETERS); CONFORMATIONAL TRANSITION; DNA RESPONSIVE ELEMENT; FLUORESCENCE; GEL MOBILITY SHIFT ASSAY; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN DNA BINDING; PROTEIN STRUCTURE; REGULATORY MECHANISM; TRANSACTIVATION;

BINDING, COMPETITIVE; CIRCULAR DICHROISM; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ESCHERICHIA COLI; MAGNESIUM; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; RESPONSE ELEMENTS; SPECTROMETRY, FLUORESCENCE; TITRIMETRY; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53; ZINC;

EID: 67651149773     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvp048     Document Type: Article

References (60)

1. Vogelstein, B., Lane, D., and Levine, A.J. (2000) Surfing the p53 network. Nature 408, 307-310
2. Lane, D.P. (1992) p53, guardian of the genome. Nature 358, 15-16
3. Levine, A.J. (1993) The tumor suppressor genes. Annu. Rev. Biochem. 62, 623-651
4. Ko, L.J. and Prives, C. (1996) p53: puzzle and paradigm. Genes Dev. 10, 1054-1072
5. Levine, A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331
6. Ding, H.F. and Fisher, D.E. (1998) Mechanisms of p53- mediated apoptosis. Crit. Rev. Oncog. 9, 83-98
7. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (Pubitemid 23346378)
8. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K., and Elledge, S.J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816 (Pubitemid 23346377)
9. Prives, C. and Hall, P.A. (1999) The p53 pathway. J. Pathol. 187, 112-126
10. Vousden, K.H. and Lu, X. (2002) Live or let die: the cell's response to p53. Nature Rev. Cancer 2, 594-604 (Pubitemid 37328926)
11. Prives, C. (1994) How loops, β sheets, and α helices help us to understand p53. Cell 78, 543-546
12. Milner, J. (1994) Forms and functions of p53. Semin. Cancer Biol. 5, 211-219
13. Anderson, M.E. and Tegtmeyer, P. (1995) Giant leap for p53, small step for drug design. BioEssays 17, 3-7
14. Bargonetti, J., Manfredi, J.J., Chen, X., Marshak, D.R., and Prives, C. (1993) A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev. 7, 2565-2574 (Pubitemid 24021013)
15. Hainaut, P., Soussi, T., Shomer, B., Hollstein, M., Greenblatt, M., Hovig, E., Harris, C.C., and Montesano, R. (1997) Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Res. 25, 151-157 (Pubitemid 27303173)
16. Pietenpol, J.A., Tokino, T., Thiagalingam, S., El-Diery, W.S., Kinzler, K.W., and Vogelstein, B. (1994) Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl Acad. Sci. USA 91, 1998-2002
17. Meek, D.W. (1998) Multisite phosphorylation and the integration of stass signals at p53. Cell. Signalling 10, 159-166
18. El-Deiry, W.S., Kern, S.E., Pietenpol, J.A., Kinzler, K.W., and Vogelstein, B. (1992) Definition of a consensus binding site for p53. Nat. Genet. 1, 45-49
19. Halazonetis, T.D. and Kandil, A.N. (1993) Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J. 12, 5057-5064 (Pubitemid 23358494)
20. Friedman, P.N., Chen, X.B., Bargonetti, J., and Prives, C. (1993) The p53 Protein is an Unusually Shaped Tetramer that Binds Directly to DNA. Proc. Natl Acad. Sci. USA 90, 3319-3323
21. Stenger, J.E., Tegtmeyer, P., Mayr, G.A., Reed, M., Wang, Y., Wang, P., Hough, P.V., and Mastrangelo, I.A. (1994) p53 oligomerization and DNA looping are linked with transcriptional activation. EMBO J. 13, 6011-6020
22. Tokino, T., Thiagalingam, S., El-Deiry, W.S., Waldman, T., Kinzler, K.W., and Vogelstein, B. (1994) p53 tagged sites from human genomic DNA. Hum. Mol. Genet. 3, 1537-1542
23. Waterman, J.L., Shenk, J.L., and Halazonetis, T.D. (1995) The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding. EMBO J. 14, 512-519
24. McNamara, P.T., Bolshoy, A., Trifonov, E.N., and Harrington, R.E. (1990) Sequence-dependent kinks induced in curved DNA. J. Biomol. Struct. Dyn. 8, 529-538
25. Zhurkin, V.B., Ulyanov, N.B., Gorin, A.A., and Jernigan, R.L. (1991) Static and statistical bending of DNA evaluated by Monte Carlo simulations. Proc. Natl Acad. Sci. USA 88, 7046-7050
26. Nagaich, A.K., Bhattacharyya, D., Brahmachari, S.K., and Bansal, M. (1994) CA/TG sequence at the 5′ end of oligo(A)- tracts strongly modulates DNA curvature. J. Biol. Chem. 269, 7824-7833
27. Werner, M.H., Gronenborn, A.M., and Clore, G.M. (1996) Intercalation, DNA kinking, and the control of transcription. Science 271, 778-784
28. Dickerson, R.E. (1998) DNA bending: the prevalence of kinkiness and the virtues of normality. Nucleic Acids Res. 26, 1906-1926
29. Olson, W.K., Gorin, A.A., Lu, X.J., Hock, L.M., and Zhurkin, V.B. (1998) DNA sequence-dependent deformability deduced from protein-DNA crystal complexes. Proc. Natl Acad. Sci. USA 95, 11163-11168
30. Cho, Y., Gorina, S., Jeffrey, P.D., and Pavletich, N.P. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-355 (Pubitemid 24259959)
31. Hainaut, P., Butcher, S., and Milner, J. (1995) Temperature sensitivity for conformation is an intrinsic property of wildtypep53. Br. J. Cancer 71, 227-231
32. Pavletich, N.P., Chambers, K.A., and Pabo, C.O. (1993) The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev. 7, 2556-2564 (Pubitemid 24021012)
33. Hainaut, P. and Milner, J. (1993) A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. Cancer Res. 53, 1739-1742
34. Meplan, C., Richard, M.J., and Hainaut, P. (2000) Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene 19, 5227-5236
35. Verhaegh, G.W., Parat, M.O., Richard, M.J., and Hainaut, P. (1998) Modulation of p53 protein conformation and DNA-binding activity by intracellular chelation of zinc. Mol. Carcinog. 21, 205-214
36. James, S.B. and Stewart, N.L. (2003) Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain. Biochem. 42, 2396-2403
37. Hainaut, P., Rolley, N., Davies, M., and Milner, J. (1995) Modulation by copper of p53 conformation and sequencespecific DNA binding: role for Cu(II)/Cu(I) redox mechanism. Oncogene 10, 27-32
38. Verhaegh, G.W., Richard, M.J., and Hainaut, P. (1997) Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper. Mol. Cell. Biol. 17, 5699-5706
39. Painter, G.R., Wright, L.L., Hopkins, S., and Furman, P.A. (1991) Initial binding of 2′-deoxynucleoside 5′-triphosphates to human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem. 15, 19362-19368
40. Bougie, I., Charpentier, S., and Bisaillon, M. (2003) Characterization of the metal ion binding properties of the hepatitis C virus RNA polymerase. J. Biol. Chem. 278, 3868-3875
41. Balagurumoorthy, P., Sakamoto, H., Lewis, M.S., Zambrano, N., Clore, G.M., Gronenborn, A.M., Appella, E., and Harrington, R.E. (1995) Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA. Proc. Natl Acad. Sci. USA 92, 8591-8595
42. Nagaich, A.K., Appella, E., and Harrington, R.E. (1997) DNA bending is essential for the site-specific recognition of DNA response elements by the DNA binding domain of the tumor suppressor protein p53. J. Biol. Chem. 272, 14842-14849
43. Nagaich, A.K., Zhurkin, V.B., Durell, S.R., Jernigan, R.L., Appella, E., and Harrington, R.E. (1997) p53-induced DNA bending and twisting: p53 tetramer binds on the outer side of a DNA loop and increases DNA twisting. Proc. Natl Acad. Sci. USA 96, 1875-1880
44. Burstein, E.A., Vedenkina, N.S., and Ivkova, M.N. (1973) Fluorescence and the location of tryptophan residues in protein molecules. Photochem. Photobiol. 18, 263-275
45. Van der Wolk, J.P.W., Klose, M., de Wit, J.G., den Blaauwen, T., Freudl, R., and Driessen, A. J. M. (1995) Identification of the magnesium-binding domain of the highaffinity ATP-binding site of the Bacillus subtilis SecA protein. J. Biol. Chem. 270, 18975-18982
46. Zhu, C.X., Roche, C.J., and Tse-Dinh, Y.C. (1997) Effect of Mg(II) binding on the structure and activity of Escherichia coli DNA topoisomerase I. J. Biol. Chem. 272, 16206-16210
47. Liu, X., Yang, J., Ghazi, A.M., and Frey, T.K. (2000) Characterization of the zinc binding activity of the rubella virus nonstructural protease. J. Virol. 74, 5949-5956 (Pubitemid 30412964)
48. Lakowicz, J.R. (1999) Principles of Fluorescence Spectroscopy, 2nd edn, pp. 237-265, Plenum Press, New York
49. Lakowicz, J.R. and Weber, G. (1973) Quenching of fluorescence by oxygen-probe for structural fluctuations in macromolecules. Biochemistry 12, 4161-4170
50. Namba, H., Hara, T., Tukazaki, T., Migita, K., Ishikawa, N., Ito, K., Nagataki, S., and Yamashita, S. (1995) Radiationinduced G1 arrest is selectively mediated by the p53-WAF1/ Cip1 pathway in human thyroid cells. Cancer Res. 55, 2075-2080
51. Bargonetti, J., Reynisdottir, I., Friedman, P.N., and Prives, C. (1992) Wild-type p53 site specific binding to cellular DNA is regulated by SV40 T antigen and mutant p53. Genes Dev. 6, 1886-1898
52. Maret, W. (2004) Zinc and sulfur: A critical biological partnership. Biochemistry 43, 3301-3309
53. Coleman, J.E. (1992) Zinc proteins: enzymes, storage proteins, transcription factors, and replication proteins. Annu. Rev. Biochem. 61, 897-946
54. Christianson, D.W. (1991) Structural biology of zinc. Adv. Protein Chem. 42, 281-355
55. Lee, M.S., Gippert, G.P., Soman, K.V., Case, D.A., and Wright, P.E. (1989) Three-dimensional solution structure of a single zinc finger DNA-binding domain. Science 245, 635-637
56. Berg, J.M. (1988) Proposed structure for the zinc-binding domains for transcription factor IIIA and related proteins. Proc. Natl Acad. Sci. USA 85, 99-102
57. 2+ on DNA recognition and stability of the p53 DNA-binding domain. Biochemistry 45, 7483-7492
58. De, A., Ramesh, V., Mahadevan, S., and Nagaraja, V. (1998) Mg2+ mediated sequence-specific binding of transcriptional activator protein C of bacteriophage Mu to DNA. Biochemistry 37, 3831-3838 (Pubitemid 28162939)
59. Romani, A.M. and Scarpa, A. (2000) Regulation of cellular magnesium. Front Biosci. 5, D720-D734
60. Romani, A.M. (2007) Magnesium homeostasis in mammalian cells. Front Biosci. 12, 308-331